4D Pharmacueticals Produce Orally Delivered Live Biotherapeutics

Phase I Clinical Trial Generates Data on Mechanism of Action, Safety and Tolerability

4D pharma plc, a pharmaceutical company focusing on the development of live biotherapeutics, today provides the following update on the phase 1 clinical trial in respect of Blautix, its proprietary single strain live biotherapeutic for the treatment of Irritable Bowel Syndrome (IBS).

Read more